Community-associated methicillin-resistant Staphylococcus aureus: reconsideration of therapeutic options

Clicks: 171
ID: 113347
2006
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #4 of 4 articles by views in current infectious disease reports

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Methicillin resistance, long recognized as characteristic of nosocomial Staphylococcus aureus, has increasingly been identified in community-acquired strains in the past 15 years. The genotypes of community-associated methicillin-resistant S. aureus (MRSA) are different from nosocomial strains, and …
Reference Key
me2006currentcommunity-associated Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Levison ME;Fung S;;
Journal current infectious disease reports
Year 2006
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/16448597
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:16448597 doi:10.1007/s11908-006-0031-7 matthew e levison shirley fung

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.